PSARLINK

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PSARLINK was filed as Word mark on 07/15/2020 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1564637
Countries Brazil Canada European Community India Japan South Korea United States of America (USA) China
Base trademark FR No. 4614473, January 15, 2020
Application date July 15, 2020
Expiration date July 15, 2030

Trademark owner

14 rue Waldeck-Rousseau
F-69006 LYON
FR

Trademark representatives

235 cours Lafayette F-69006 LYON FR

goods and services

01 Chemical, biochemical, biological and biotechnological preparations for scientific use; chemical substances for manufacturing pharmaceutical products; chemical substances for connecting molecules, in particular chemical substances for linking molecules for cancer therapy, for research into active ingredients and medicines; chemical substances for forming antibody conjugates; chemical reagents for scientific purposes other than for medical or veterinary use; reagents for scientific or medical research; chemical, biochemical and biological reagents and especially a technological platform in the form of or used for creating or improving antibody drug conjugates or any protein combined with a medicine, a polynucleotide, another protein, a chemical entity or another functional entity for industry and the sciences; chemical products for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary use; antibodies for scientific or medical research; molecules and biomolecules, especially reagents, antibody fragments, antibodies, all for use in fundamental research and development, medical research as well as scientific diagnosis; diagnostic products for scientific use or for research in connection with antibody conjugates (medicines)
05 Pharmaceutical preparations; pharmaceutical products especially for the prevention or treatment of human diseases; chemical, biological and biochemical products for medical and pharmaceutical use, especially, antibody drug conjugates or any protein combined with a medicine, a polynucleotide, another protein, a chemical entity, or another functional entity or these products used as binders or payload molecules; pharmaceutical preparations especially bioconjugates for use in diagnosis and for the treatment of diseases; antibody products, especially, antibody or protein bioconjugates for use in medical diagnosis and the treatment of diseases including antibody/protein drug conjugates, antibody/protein labelled conjugates and antibody/protein imaging agent conjugates; antibody administration devices (medical and pharmaceutical preparations); molecules and biomolecules, especially, reagents, antibody fragments, antibodies, all for use in medical diagnosis and the treatment of disease; pharmaceutical products, medical preparations and products, especially antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; chemical reagents for functionalizing biomolecules for medical use

Trademark history

Date Document number Area Entry
June 24, 2022 2022/26 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 12, 2022 2022/20 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 18, 2022 2022/16 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 5, 2022 2022/14 Gaz CA Rejection
January 3, 2022 2022/1 Gaz KR Rejection
November 16, 2021 2021/46 Gaz BR Rejection
November 4, 2021 2021/44 Gaz JP Rejection
April 28, 2021 2021/17 Gaz EM Rejection
April 7, 2021 2021/14 Gaz CN Rejection
January 5, 2021 2021/1 Gaz US Rejection
December 28, 2020 2021/1 Gaz IN Rejection
July 15, 2020 2020/48 Gaz FR Registration

ID: 141564637